Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
www.jetir.org/ (ISSN-2349-5162) Ahmed MB, Islam SU, Alghamdi AA, Kamran M, Ahsan H, Lee YS (2022) Phytochemicals as chemo-preventive agents and signaling molecule modulators: current role in cancer therapeutics and inflammation
We believe that that's the bar
Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD
These studies focus on signaling interactions rather than neurological outcomes
Ultimately, if you are not eating a healthy protein-filled diet while on medication, you are unlikely to stick to that diet after you get off the meds
NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimers disease
